You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Claims for Patent: 5,214,052

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 5,214,052

Title:	Method for dissolving arginineamides and pharmaceutical compositions containing them
Abstract:	A method for dissolving an arginineamide of the invention comprising dissolving N2-arylsulfonyl-L-arginineamide having the general formula (I) (I) wherein R1 represents a (2R, 4R)-4-alkyl-2-carboxypiperizino group and R2 represents a phenyl group or a condensed polycyclic compound residue which may be substituted with one or more substituents selected from lower alkyl groups, lower alkoxy groups and lower alkyl-substituted amino groups, said condensed polycyclic compound residue including a benzene ring which binds to sulfur atom of the sulfonyl group in the general formula (I) and is condensed with one or more other rings which may be heterocyclic and having 7 to 14 carbon atoms as the ring-constituent atoms; and/or its salt in a solvent of alcohol and water is disclosed herein. And, the pharmaceutical composition comprising N2-arylsulfonyl-L-arginineamide having the general formula (I), an alcohol and water is disclosed herein.
Inventor(s):	Kunihiko Ofuchi, Tatsuo Nomura
Assignee:	Mitsubishi Chemical Corp
Application Number:	US07/851,248
Patent Claims:

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.